Korth, DE
Benjamin S. Korth, Duesseldorf DE
Patent application number | Description | Published |
---|---|---|
20150030813 | SPLICING TAPE FOR CONTINUOUS ROLL CHANGE AND METHOD OF MANUFACTURE - The present invention relates to a splicing tape ( | 01-29-2015 |
Carsten Korth, Dusseldorf DE
Patent application number | Description | Published |
---|---|---|
20080286197 | Antibody for Diagnosing and Treating Neuropsychiatric Diseases, in Particular Schizophrenia, Depression and Bipolar Affective Disorders - An antibody for diagnosis or treatment of neuropsychiatric diseases, in particular schizophrenia, depression or bipolar affective disorders, is characterized in that the antibody recognizes misfolded specific proteins that can be assigned to one of the diseases, and a method for diagnosis by means of antibodies that bind to neuropsychiatric disease-specific proteins. | 11-20-2008 |
20090124001 | 9-AMINO-ACRIDINE DERIVATIVES AND THEIR USE FOR ELIMINATING MISFOLDED PROTEINS - The invention relates to compounds according to general formula (1) and/or their enantiomers, diastereomers as well as their pharmaceutically compatible salts, and to the use thereof for producing a medicament suited for treating diseases associated with misfolded proteins. | 05-14-2009 |
20090209516 | 9-AMINO-ACRIDINE DERIVATIVES AND METHOD OF TREATING AUTOIMMUNE DISEASES USING THE SAME - The invention relates to compounds according to general formula (1) and/or their enantiomers, diastereomers, and their pharmaceutically compatible salts, and their use to manufacture a medication as well as medications. The compounds are suited for treatment of diseases connected with misfolded proteins. | 08-20-2009 |
20110033477 | METHOD FOR DIAGNOSING AND TREATING CHRONIC PSYCHIATRIC ILLNESSES AND MARKERS AND TARGETS FOR SUCH METHODS - The invention relates to the use of special conformers of the DISC1 protein as a marker or target for chronic psychiatric illnesses, particularly schizophrenia, bipolar disorder, or depression. | 02-10-2011 |
20110098448 | ANTI-PRION PROTEIN ANTIBODY FRAGMENT - The invention relates to an antibody, antibody fragment or derivative thereof which specifically recognizes a prion protein and which comprises a complementarity determining region (CDR), a retro-inverso D-peptide of said CDR and/or an anti-idiotypic antibody, antibody fragment or derivative thereof which recognizes said CDR. The invention further concerns a nucleic acid molecule encoding said antibody, antibody fragment or derivative thereof as well as a method for generating an antibody, antibody fragment or derivative thereof that specifically recognizes a prion protein, wherein an antibody that recognizes a specific domain of the prion protein is generated, an antigen-specific amino acid sequence is isolated from said antibody, and an anti-idiotypic antibody, antibody fragment or derivative thereof, which recognizes said antigen-specific amino acid sequence, is generated. | 04-28-2011 |
Carsten Korth, Duesseldorf DE
Patent application number | Description | Published |
---|---|---|
20110243949 | COMPOSITION FOR PRODUCING ANTI-AMYLOID BETA PEPTIDE ANTIBODIES WITH D-PEPTIDES - The present invention relates to a composition comprising D-peptides or antibodies for use as a therapeutic and/or for disease prevention, wherein | 10-06-2011 |
Karsten Korth, Grenzach-Wyhlen DE
Patent application number | Description | Published |
---|---|---|
20080319128 | Method for the production of (Mercaptoorgany)alkyl polyether silanes - The invention relates to a method for producing (mercaptoorganyl)alkyl polyether silanes by reacting dry mercaptization reagents with a (haloorganyl)alkyl polyether silane. | 12-25-2008 |
20090221751 | Rubber Mixtures - Rubber mixtures, including at least one rubber, a filler, an organosilicon compound of the formula I | 09-03-2009 |
20090312476 | Rubber Mixtures - The invention relates to rubber mixtures, comprising: (A) at least one rubber, (B) at least one oxidic filler and (C) at least one (haloorganyl)alkylpolyethersilane of the general formula (X)(X′)(X″)Si—R | 12-17-2009 |
20100029971 | PROCESS FOR PREPARING ORGANOSILANES - The invention relates to a process for preparing organosilanes of the general formula I | 02-04-2010 |
20100217026 | Method for producing organosilanes - The invention relates to a method for producing organosilanes of general formula I, | 08-26-2010 |
20110034584 | MIXTURES OF SILICON-CONTAINING COUPLING REAGENTS - Mixtures of silicon-containing coupling reagents comprising (mercaptoorganyl)alkylpolyethersilanes containing silanol groups and (mercaptoorganyl)alkylpolyethersilanes free of silanol groups in a weight ratio of from 5:95 to 95:5. The mixtures can be prepared by transesterification and hydrolysis. The mixtures can be used in rubber mixtures. | 02-10-2011 |
20110287205 | Mercaptosilanes - Mercaptosilanes are disclosed of the formula I | 11-24-2011 |
20130012691 | Process for Preparing Silicon-Containing Azodicarbamides - The invention relates to a process for preparing silicon-containing azodicarbamides of the general formula (I) (R | 01-10-2013 |
Mirko Korth, Ulm DE
Patent application number | Description | Published |
---|---|---|
20110169250 | VEHICLE SEAT ARRANGEMENT AND AIRBAG ARRANGEMENT FOR A MOTOR VEHICLE AND A METHOD FOR PROTECTING A VEHICLE OCCUPANT - A vehicle seat arrangement for a motor vehicle is provided. The vehicle seat arrangement comprising a vehicle seat, which comprises at least one inflatable element for protecting a vehicle occupant residing on the vehicle seat. The inflatable element is formed and arranged such that said element expands predominantly in direction towards the vehicle occupant when inflated. The inflatable element is integrated into a backrest of the vehicle seat unfolded or provided with only one fold or a protuberance, wherein the inflatable element is arranged between a cushion of the vehicle seat and a cover of the vehicle seat or inside the cushion. | 07-14-2011 |
Ruth-Maria Korth, Munchen DE
Patent application number | Description | Published |
---|---|---|
20090324518 | Novel Compositions Against Alkyl-Acyul-GPC The Derivatitves and Products Thereof - The invention refers to novel compositions with at least one prehormone, hormone from group consisting of mevalonate derivatives or from the group consisting of peptides and/or proteo-hormones and at least one mineral, one constituent by preference from the group consisting of iodine, selen and at least one Ginkgoloide against alkyl-acyl-GPC (AAGPC), its derivatives (alkyl-lipis) and/or products (e.g. acetylacyl-CoA). In addition, the invention also refers to the manufacture of novel compositions with at least one Ginkgoloide and/or acetylcysteine for oral, dietary, oily or local, cosmetic administration. Novel local preparations without ether/volatile oils contain Ginkgoloides with at least one sun screening agent against impairments of pigmentation. | 12-31-2009 |
Ruth-Maria Korth, Munich DE
Patent application number | Description | Published |
---|---|---|
20110038813 | Novel Compositions Against Alkyl-Acyl GPC, The Derivatives And Products Thereof - The invention refers to novel compositions with at least one prehormone, hormone from group consisting of mevalonate derivatives or from the group consisting of peptides and/or proteo-hormones and at least one mineral, one constituent by preference from the group consisting of iodine, selen and at least one Ginkgoloide against alkyl-acyl-GPC (AAGPC), its derivatives (alkyl-lipis) and/or products (e.g. acetylacyl-CoA). In addition, the invention also refers to the manufacture of novel compositions with at least one Ginkgoloide and/or acetylcysteine for oral, dietary, oily or local, cosmetic administration. Novel local preparations without ether/volatile oils contain Ginkgoloides with at least one sun screening agent against impairments of pigmentation. The compositions of the invention are used for the manufacture of compounds to protect against alkylacyl-like destabilized cells by preference under the conditions of critical lifestyle. Persons are clinically treated who have problems concerning body weight, critical morning urine samples, tendency to diabetes and hypersensitivity syndromes and/or desequilibration of mentality and mind. | 02-17-2011 |
Steffen Korth, Elleben DE
Patent application number | Description | Published |
---|---|---|
20090112102 | Therapy device with a time-variable blood regulation - A therapy device having a blood pressure device and a regulating device for a time-variable regulation of the blood pressure, which decides, during a therapy procedure, dependent on detected blood pressure value, whether the blood regulation is continued with hypothetical or with real blood pressure values. The regulating device processes various categories of blood pressure values, i.e. blood pressure values obtained by the regulating device according to an implemented time schedule, blood pressure values requested by measurement and evaluation device, and blood pressure values requested by medical staff. Besides the regular triggers (RT) generated at regular intervals, the irregular triggers (IRT) and the quasi-regular triggers (QRT) requested externally at respective times are also evaluated. | 04-30-2009 |
20100016776 | TREATMENT DEVICE WITH MEMORY-SUPPORTED CONTROL MEANS - The therapy device stores the time profiles of the blood pressure and of other influencing variables during preceding therapy procedures. The time profile of the blood pressure and of other influencing variables during the actual therapy is also recorded. An analytical comparison is then made between the time profiles of the blood pressure and of other influencing variables during the actual measurement procedure and those during preceding therapy procedures. Depending on the comparison, a prospective blood pressure control is carried out in order to prevent drops in blood pressure in a subsequent time period. | 01-21-2010 |
Wolfgang Korth, Bayreuth DE
Patent application number | Description | Published |
---|---|---|
20090264691 | POROUS HETEROGENEOUS CATALYST COATED WITH AN IONIC LIQUID - The invention relates to a porous heterogeneous catalyst. In order to prepare a catalyst which catalyzes with a relatively high selectivity the hydrogenation of individual unsaturated bonds of polyunsaturated compounds it is proposed that the inner surface of the catalysts is coated with an ionic liquid. | 10-22-2009 |